SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,729.27 413.66
( 0.56%)

Global Indices

Nasdaq

52,025.19 -173.50
(-0.33%)

Dow Jones

7,682.22 -82.84
(-1.07%)

Hang Seng

65,489.63 1,063.68
(1.65%)

Nikkei 225

10,879.96 39.61
(0.37%)

Forex

USD-INR

94.85 -0.23
(-0.24%)

EUR-INR

106.35 0.11
(0.11%)

GBP-INR

125.73 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

JFL Life Sciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

535469

INE0LA901015

13.9017348

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JFLLIFE

5.29

35.8

EPS(TTM)

Face Value()

Div & Yield %

2.05

Back

Gallantt Ispat consolidated net profit declines 28.84% in the June 2026 quarter

Jul 28,2026

Net profit of Gallantt Ispat declined 28.84% to Rs 123.67 crore in the quarter ended June 2026 as against Rs 173.79 crore during the previous quarter ended June 2025. Sales rose 1.59% to Rs 1145.67 crore in the quarter ended June 2026 as against Rs 1127.78 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1145.67	1127.78	2
OPM %	16.16	21.89	-
PBDT	194.93	248.03	-21
PBT	164.81	216.37	-24
NP	123.67	173.79	-29

74,729.27 413.66 ( 0.56%)

52,025.19 -173.50 (-0.33%)

7,682.22 -82.84 (-1.07%)

65,489.63 1,063.68 (1.65%)

10,879.96 39.61 (0.37%)

94.85 -0.23 (-0.24%)

106.35 0.11 (0.11%)

125.73 -0.01 (-0.01%)

0.60 0.00 (0.07%)